STOCK TITAN

[Form 4] MEDICAL PROPERTIES TRUST INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Insider grant and ownership change at Medical Properties Trust (MPW). Larry H. Portal, SVP and Senior Advisor to the CEO, was reported as acquiring two equity awards on 09/24/2025. One grant of 59,743 common shares vests quarterly through March 31, 2028 and increased his beneficial ownership to 463,589 shares. A second performance-based grant of 25,058 shares is contingent on three-year total shareholder return (TSR) hurdles through April 14, 2028 (20% TSR = 100% payout; 40% = 200%; 60% = 300%); if earned, those shares vest in equal quarterly installments over the following year or in full upon final Compensation Committee determination, subject to continued employment. The Form 4 was filed 09/26/2025 and signed by a power of attorney.

Grant interno e cambio di proprietà presso Medical Properties Trust (MPW). Larry H. Portal, SVP e Senior Advisor al CEO, è stato segnalato come beneficiario di due awards azionari il 24/09/2025. Un premio di 59.743 azioni ordinarie che vestono trimestralmente fino al 31 marzo 2028 ha aumentato la sua proprietà beneficiaria a 463.589 azioni. Un secondo premio basato sulle performance di 25.058 azioni è condizionato a tre soglie di total shareholder return (TSR) su tre anni fino al 14 aprile 2028 (20% TSR = payout al 100%; 40% = 200%; 60% = 300%); se maturato, tali azioni vestono in rate trimestrali uguali durante l'anno successivo oppure per intero al momento della determinazione finale del Compensation Committee, soggetto a proseguimento dell’impiego. Il Form 4 è stato depositato il 26/09/2025 e firmato da una procura.

Concesión interna y cambio de propiedad en Medical Properties Trust (MPW). Larry H. Portal, vicepresidente senior y Asesor Senior del CEO, fue reportado como solicitante de dos premios de acciones el 24/09/2025. Una adjudicación de 59,743 acciones comunes se consolida de forma trimestral hasta el 31 de marzo de 2028 y eleva su propiedad beneficial a 463,589 acciones. Otro premio basado en rendimiento de 25,058 acciones depende de tres umbrales de rendimiento total para los accionistas (TSR) durante tres años hasta el 14 de abril de 2028 (20% TSR = 100% pago; 40% = 200%; 60% = 300%); si se gana, esas acciones se consolidan en cuotas trimestrales iguales durante el año siguiente o en su totalidad tras la determinación final del Comité de Compensación, sujeto a continuidad en el empleo. El Formulario 4 se presentó el 26/09/2025 y fue firmado por un poder notarial.

의료 재산 신탁 MPW에서의 내부 보조금 및 소유권 변경. Larry H. Portal, CEO에게 차장 고문 겸 선임 고문은 2025년 9월 24일 두 건의 주식 수여를 취득한 것으로 보고되었습니다. 59,743주 보통주가 2028년 3월 31일까지 분기별로 vest되며 그의 수혜 소유권을 463,589주로 증가시켰습니다. 세 번째로 보상 기반의 25,058주 역시 3년간의 총주주수익(TSR) 허들이 2028년 4월 14일까지 충족될 경우에만 vest되며(TSR 20% = 100% 지급; 40% = 200%; 60% = 300%), 획득 시 해당 주식은 이후 1년간 분기별로 균등하게 vest되거나 Compensation Committee의 최종 결정 시점에 전액 vest됩니다. 고용 지속 여부에 따라 달라집니다. Form 4는 2025년 9월 26일에 제출되었으며 대리인이 서명했습니다.

Attribution et changement de propriété chez Medical Properties Trust (MPW). Larry H. Portal, vice-président senior et conseiller principal du PDG, a été signalé comme acquérant deux attributions d’actions le 24/09/2025. Une attribution de 59 743 actions ordinaires vestes trimestriellement jusqu’au 31 mars 2028 et portait sa propriété bénéficiaire à 463 589 actions. Une deuxième attribution axée sur la performance de 25 058 actions dépend de trois paliers de TSR sur trois ans jusqu’au 14 avril 2028 (20% TSR = 100% du paiement; 40% = 200%; 60% = 300%); si acquise, ces actions vestent en versements trimestriels égaux au cours de l’année suivante ou en totalité lors de la détermination finale par le Comité de rémunération, sous réserve du maintien de l’emploi. Le Form 4 a été déposé le 26/09/2025 et signé par une procuration.

Interner Zuschuss und Eigentumsänderung bei Medical Properties Trust (MPW). Larry H. Portal, Senior Vice President und Senior Advisor des CEO, wurde am 24.09.2025 als Erwerber von zwei Aktienzusagen gemeldet. Ein Zuwachs von 59.743 Stammaktien vestet quartalsweise bis zum 31. März 2028 und erhöht sein beneficial ownership auf 463.589 Aktien. Eine zweite leistungsabhängige Zuwendung von 25.058 Aktien hängt von drei jährlichen TSR-Hürden bis zum 14. April 2028 ab (20% TSR = 100% Auszahlung; 40% = 200%; 60% = 300%); bei Erwerb vesten diese Aktien in gleichen vierteljährlichen Raten über das folgende Jahr oder vollständig nach endgültiger Festlegung durch den Compensation Committee, vorausgesetzt, die Anstellung besteht fort. Das Formular 4 wurde am 26.09.2025 eingereicht und von einer Vollmacht unterzeichnet.

منحة داخلية وتغيير الملكية في Medical Properties Trust (MPW). تم الإبلاغ عن أن لاري إتش. بورتال، نائب الرئيس الأول والمستشار الكبير للرئيس التنفيذي، قد حصل على عقدين للأسهم في 24/09/2025. منحة واحدة قدرها 59,743 سهماً عادياً تقيد وفق ربع سنوي حتى 31 مارس 2028 ورفعت ملكيته المستفادة إلى 463,589 سهماً. منحة أخرى قائمة على الأداء قدرها 25,058 سهماً مشروطة بمستويات TSR لمدة ثلاث سنوات حتى 14 أبريل 2028 (20% TSR = دفع 100%؛ 40% = 200%؛ 60% = 300%); إذا تحققت، فإن هذه الأسهم تتقادم بنسب ربع سنوية متساوية خلال السنة التالية أو بالكامل عند قرار لجنة التعويض النهائي، رهناً باستمرار التوظيف. تم إعداد النموذج Form 4 في 26/09/2025 وتوقيعه بواسطة توكيل.

Medical Properties Trust(MPW)的内部赠予与所有权变更。 Larry H. Portal,高级副总裁兼首席执行官高级顾问,已于2025年9月24日被报道获得两项股票奖励。其中一项为59,743股普通股,按季度分期归属至2028年3月31日,致使其实际持股至多达463,589股。另一项基于绩效的奖励为25,058股,须在三年总股东回报(TSR)门槛下方可在2028年4月14日之前实现;若达成,相关股票将于随后的年度内按等额季度分期归属,或在薪酬委员会最终裁定时一次性归属,前提是仍然在职。Form 4已于2025年9月26日提交,并由授权书签署。

Positive
  • Management-shareholder alignment through time-based and TSR-linked equity awards
  • Transparent performance hurdles (20%/40%/60% TSR mapped to 100%/200%/300% payouts) with linear interpolation
  • Retention-focused vesting with quarterly vesting through March 31, 2028 and post-performance quarterly vesting
Negative
  • Performance tranche is contingent on achieving specified TSR hurdles through April 14, 2028, so upside is not guaranteed
  • Filing lacks grant-date valuation, so investors cannot assess compensation cost or dilution from this form alone
  • Continued employment requirement may limit liquidity and immediate alignment if the executive departs

Insights

TL;DR Routine executive equity grants align management with shareholders but include multi-year performance and vesting conditions.

The awards combine time-based and performance-based equity, a common design to retain senior executives and link pay to shareholder outcomes. The time-vested tranche vests quarterly through March 2028 providing steady alignment. The performance tranche ties payout to explicit TSR hurdles over a three-year period, with escalation from 100% to 300% based on 20%–60% TSR outcomes. The structure preserves accountability via continued employment requirements and final Compensation Committee determination. This disclosure appears standard and informational rather than transformational for investors.

TL;DR Mix of quarterly time vesting and aggressive TSR-based upside; materiality is moderate given the award sizes versus total holdings.

The time-based award of 59,743 shares and the potential 25,058 performance shares increase reported beneficial ownership to 488,647 if performance shares are earned. The performance metrics use clear TSR hurdles with linear interpolation between levels, which creates transparent payout mechanics. Vesting schedules extend to 2028, emphasizing retention. The filing does not disclose grant-date fair value or proportion of annual equity opportunity, so absolute compensation impact cannot be determined from this form alone.

Grant interno e cambio di proprietà presso Medical Properties Trust (MPW). Larry H. Portal, SVP e Senior Advisor al CEO, è stato segnalato come beneficiario di due awards azionari il 24/09/2025. Un premio di 59.743 azioni ordinarie che vestono trimestralmente fino al 31 marzo 2028 ha aumentato la sua proprietà beneficiaria a 463.589 azioni. Un secondo premio basato sulle performance di 25.058 azioni è condizionato a tre soglie di total shareholder return (TSR) su tre anni fino al 14 aprile 2028 (20% TSR = payout al 100%; 40% = 200%; 60% = 300%); se maturato, tali azioni vestono in rate trimestrali uguali durante l'anno successivo oppure per intero al momento della determinazione finale del Compensation Committee, soggetto a proseguimento dell’impiego. Il Form 4 è stato depositato il 26/09/2025 e firmato da una procura.

Concesión interna y cambio de propiedad en Medical Properties Trust (MPW). Larry H. Portal, vicepresidente senior y Asesor Senior del CEO, fue reportado como solicitante de dos premios de acciones el 24/09/2025. Una adjudicación de 59,743 acciones comunes se consolida de forma trimestral hasta el 31 de marzo de 2028 y eleva su propiedad beneficial a 463,589 acciones. Otro premio basado en rendimiento de 25,058 acciones depende de tres umbrales de rendimiento total para los accionistas (TSR) durante tres años hasta el 14 de abril de 2028 (20% TSR = 100% pago; 40% = 200%; 60% = 300%); si se gana, esas acciones se consolidan en cuotas trimestrales iguales durante el año siguiente o en su totalidad tras la determinación final del Comité de Compensación, sujeto a continuidad en el empleo. El Formulario 4 se presentó el 26/09/2025 y fue firmado por un poder notarial.

의료 재산 신탁 MPW에서의 내부 보조금 및 소유권 변경. Larry H. Portal, CEO에게 차장 고문 겸 선임 고문은 2025년 9월 24일 두 건의 주식 수여를 취득한 것으로 보고되었습니다. 59,743주 보통주가 2028년 3월 31일까지 분기별로 vest되며 그의 수혜 소유권을 463,589주로 증가시켰습니다. 세 번째로 보상 기반의 25,058주 역시 3년간의 총주주수익(TSR) 허들이 2028년 4월 14일까지 충족될 경우에만 vest되며(TSR 20% = 100% 지급; 40% = 200%; 60% = 300%), 획득 시 해당 주식은 이후 1년간 분기별로 균등하게 vest되거나 Compensation Committee의 최종 결정 시점에 전액 vest됩니다. 고용 지속 여부에 따라 달라집니다. Form 4는 2025년 9월 26일에 제출되었으며 대리인이 서명했습니다.

Attribution et changement de propriété chez Medical Properties Trust (MPW). Larry H. Portal, vice-président senior et conseiller principal du PDG, a été signalé comme acquérant deux attributions d’actions le 24/09/2025. Une attribution de 59 743 actions ordinaires vestes trimestriellement jusqu’au 31 mars 2028 et portait sa propriété bénéficiaire à 463 589 actions. Une deuxième attribution axée sur la performance de 25 058 actions dépend de trois paliers de TSR sur trois ans jusqu’au 14 avril 2028 (20% TSR = 100% du paiement; 40% = 200%; 60% = 300%); si acquise, ces actions vestent en versements trimestriels égaux au cours de l’année suivante ou en totalité lors de la détermination finale par le Comité de rémunération, sous réserve du maintien de l’emploi. Le Form 4 a été déposé le 26/09/2025 et signé par une procuration.

Interner Zuschuss und Eigentumsänderung bei Medical Properties Trust (MPW). Larry H. Portal, Senior Vice President und Senior Advisor des CEO, wurde am 24.09.2025 als Erwerber von zwei Aktienzusagen gemeldet. Ein Zuwachs von 59.743 Stammaktien vestet quartalsweise bis zum 31. März 2028 und erhöht sein beneficial ownership auf 463.589 Aktien. Eine zweite leistungsabhängige Zuwendung von 25.058 Aktien hängt von drei jährlichen TSR-Hürden bis zum 14. April 2028 ab (20% TSR = 100% Auszahlung; 40% = 200%; 60% = 300%); bei Erwerb vesten diese Aktien in gleichen vierteljährlichen Raten über das folgende Jahr oder vollständig nach endgültiger Festlegung durch den Compensation Committee, vorausgesetzt, die Anstellung besteht fort. Das Formular 4 wurde am 26.09.2025 eingereicht und von einer Vollmacht unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Portal Larry H

(Last) (First) (Middle)
1000 URBAN CENTER DRIVE
SUITE 501

(Street)
BIRMINGHAM AL 35242

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MEDICAL PROPERTIES TRUST INC [ MPW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Senior Advisor to the CEO
3. Date of Earliest Transaction (Month/Day/Year)
09/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.001 09/24/2025 A 59,743(1) A $0.00 463,589 D
Common stock, par value $0.001 09/24/2025 A 25,058(2)(3) A $0.00 488,647 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares vest at the beginning of each calendar quarter ending March 31, 2028.
2. The shares were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period ending April 14, 2028 as follows: (i) if the Company's TSR reaches 20%, 100% of the shares will be earned; (ii) if the Company's TSR reaches 40%, 200% of the shares will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the shares will be earned. The actual number of shares to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 3).
3. Earned shares will become vested in equal quarterly installments over one year following the date the shares are earned, provided that all unvested earned shares will vest in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.
W. Zachary Riddle, by power of attorney 09/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What changes in MPW ownership are reported for Larry H. Portal?

The filing reports acquisition of 59,743 time-vested shares (vesting quarterly through March 31, 2028) and 25,058 performance-based shares contingent on TSR, increasing reported beneficial ownership to 488,647 if performance shares are earned.

When were the transactions reported on the Form 4 for MPW?

The transactions have a transaction date of 09/24/2025 and the Form 4 was filed and signed on 09/26/2025.

What are the performance conditions for the MPW award?

Performance shares are earned based on three-year total shareholder return to April 14, 2028: 20% TSR = 100% payout, 40% TSR = 200% payout, 60% TSR = 300% payout, with linear interpolation between hurdles.

How do the performance shares vest if earned?

If earned, performance shares vest in equal quarterly installments over one year after being earned, or in full when the Compensation Committee makes the final determination following the three-year period, subject to continued employment.

Who filed and signed the Form 4 for Larry H. Portal?

The Form 4 was signed by W. Zachary Riddle by power of attorney on 09/26/2025.
Medical Prop

NYSE:MPW

MPW Rankings

MPW Latest News

MPW Latest SEC Filings

MPW Stock Data

2.94B
497.16M
17.3%
59.5%
27.66%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
BIRMINGHAM